Vectibix (Amgen Inc)
Welcome to the PulseAid listing for the Vectibix drug offered from Amgen Inc. This Epidermal Growth Factor Receptor Antagonist [EPC],HER1 Antagonists [MoA],Antibodies, Monoclonal [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Amgen Inc |
| NON-PROPRIETARY NAME: | panitumumab |
| SUBSTANCE NAME: | PANITUMUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Epidermal Growth Factor Receptor Antagonist [EPC],HER1 Antagonists [MoA],Antibodies, Monoclonal [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2006-10-10 |
| END MARKETING DATE: | 0000-00-00 |
Vectibix HUMAN PRESCRIPTION DRUG Details:
| Item Description | Vectibix from Amgen Inc |
| LABELER NAME: | Amgen Inc |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/5mL) |
| START MARKETING DATE: | 2006-10-10 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 55513-954_66724e29-088b-40a9-8d6f-979bda438cf2 |
| PRODUCT NDC: | 55513-954 |
| APPLICATION NUMBER: | BLA125147 |
Other PANITUMUMAB Pharmaceutical Manufacturers / Labelers:
